292
A summary of flap cases for head and neck oncology at
University College London Hospital between September
2015 and August 2016
H. Mohamedbhai
∗
, S. Thomas, R. Nekrasius, I. Hutchinson,
N. Kalavrezos, Z. Sadiq
University College London Hospital, London, United Kingdom
An analysis was conducted of all patients undergoing flap surgery
for the treatment of head and neck cancers between September
2015 and August 2016. 57 patients underwent flap surgery, 72%
for SCC, 21.0% for sarcoma and 7% for other. Of these, 9/57 had
previous head and neck cancer. The median time fromfirst surgical
clinic until surgery was 41 days while the median time from first
multidisciplinary team (MDT) meeting to surgery was 27 days.
Of the flap cases: 19/57 were radial forearm, 17/57 fibula,
seven pectoralis major, three latissimus dorsi, two anterolateral
thigh, two facial artery musculomucosal and five other. 66.7% of
patients underwent a surgical tracheostomy and 78.9% had at least
one dental extraction. The median inpatient stay was 14 days and
the median intensive care unit stay was two days. 26.3% had no
complications while 31.6% had grade 1, 17.6% a grade 2, 10.5%
a grade 3a, 7% grade 3b and 7% grade 4a
. 1 There were a total of
eight returns to theatre, with a total of three flap failures (5.3%),
two flap salvages (3.5%) and three other causes. The final histol-
ogy diagnosis correlated with the initial MDT diagnosis 93.8%
of the time. Initial MDT TNM staging correlated with final TNM
staging with 67.6% of patients. Margins were 5 mm or greater in
62.5% of patients.
Reference
1. Dindo, D., Demartines, N., & Clavien, P. A. (2004). Classification of
surgical complications: a new proposal with evaluation in a cohort of
6336 patients and results of a survey.
Ann Surg
,
240
, 205–213.
http://dx.doi.org/10.1016/j.ijom.2017.02.982Pleomorphic adenoma of the parotid gland: institutional
experience and review of the literature
C. Moss
∗
, V. Ranjitsingh, T. Sandhu, N. Kalavrezos, Z. Sadiq
University College Hospital, London, United Kingdom
Background:
Pleomorphic adenoma is the commonest salivary
gland tumour. It has the tendency to recur and the ability to undergo
malignant transformation. The management of pleomorphic ade-
noma of the parotid gland is surrounded with controversy in terms
of surgical approach and long-term outcomes.
Methods:
All patients who were operated for pleomorphic ade-
noma of the parotid gland between the years 2000 and 2016 were
reviewed. Patient demographics, clincopathologic variables and
operative details were collected retrospectively.
Results:
A total of 246 patients were identified. Superficial
parotidectomy was found to be the procedure of choice over extra-
capsular dissection in our institution. Recurrence rate was found to
be consistent with those reported in the current literature. Despite
the comparatively more invasive nature of superficial parotidec-
tomy, long-term complication rate remains low in experienced
hands.
Conclusion:
A general consensus in the surgical management
of parotid pleomorphic adenoma is yet to be reached. Our insti-
tutional experience over the last 16 years favours superficial
parotidectomy for most cases, nevertheless we believe there is
merit in performing extracapsular dissection on selected cases of
small, superficial parotid pleomorphic adenomas.
http://dx.doi.org/10.1016/j.ijom.2017.02.983Prediction of acute radiation mucositis using an oral mucosal
dose surface model in intensity modulated radiation therapy
for head and neck tumours
A. Musha
∗
, S. Yokoo
Department of Stomatology and Maxillofacial Surgery, Gunma
University Graduate School of Medicine, Gunma, Japan
Background and Objectives:
To evaluate the dose-response rela-
tionship for development of acute radiation mucositis (ARM)
using an oral mucosal dose surface model (OMDS-model) in
intensity modulated radiation therapy (IMRT) for head and neck
tumours.
Methods:
37 patients receiving IMRT for head and neck cancer
were evaluated for ARM (once per week for six weeks) accord-
ing to the Common Terminology Criteria for Adverse Events
(CTCAE), version 4.0, and the Radiation Therapy Oncology
Group (RTOG) scoring systems. The irradiation schedule typ-
ically used was 40–70 Gy in 20–35 fractions for four to seven
weeks. Maximum point doses in the tongue were compared with
ARM in each patient.
Findings:
The location of the ARM coincided with the high-dose
area in the OMDS-model. There was a clear dose-response rela-
tionship between maximum point dose and ARM. The threshold
doses for grade 1 and 2 ARM in the tongue were 53.9 Gy and
70.3 Gy, respectively.
Conclusions:
The OMDS-model was useful for predicting the
location and severity of ARM. Maximum point doses in the model
correlated well with grade 1–2 ARM.
http://dx.doi.org/10.1016/j.ijom.2017.02.984A single centre experience of head and neck cutaneous
pleomorphic dermal sarcoma
M. Patel
∗
, N. Chaston, A. Kichenaradjou
Department of Oral and Maxillofacial Surgery, East Kent
Hospital, Ashford, United Kingdom
Background:
Pleomorphic neoplasms are understood to have
high-grade malignant behaviour. This does not readily apply to
primary cutaneous tumours. The behaviour of these tumours is
varied, requiring confident diagnosis to reliably predict behaviour
and guide treatment. Diagnosis is challenging because of signif-
icant clinical and pathological overlap of cutaneous pleomorphic
neoplasms.
Pleomorphic dermal sarcoma (PDS) is a tumour with
morphologic and immunohistochemical features of atypical
fibroxanthoma (AFX) and in the past they were regarded together
with AFX. The separation from AFX is important due to low-
grade malignant potential of PDS with risk for local recurrence
and metastasis. PDS affects sun-damaged skin of the elderly with
a strong male predilection with often a preference for the scalp.
A short history of rapid growth is characteristic and ulceration
and bleeding are common. PDS is best regarded as a tumour of




